Jake Ghannam took to LinkedIn to announce that he accepted the position of chief commercial officer (CCO) at Insightec.
Ghannam said his appointment at Insightec means he departs his post as EVP for U.S. and Canada at GE HealthCare. According to his LinkedIn profile, he spent more than two-and-a-half years at GE HealthCare. Before that, he spent more than eight years at Medtronic, culminating in the position of senior
He said that a formal announcement from Insightec should soon follow.
“After an incredible journey with GE HealthCare, I’m excited to share that I’ve accepted the role of Chief Commercial Officer of Insightec,” he wrote in his LinkedIn post. “This decision wasn’t easy, as my time at GE HealthCare has been filled with invaluable experiences and relationships. Together, we’ve made a significant impact on healthcare, and I’m deeply grateful for the journey.”
Haifa, Israel–based Insightec — which has its U.S. headquarters in Miami — develops focused ultrasound technology. Its Exablate Prime platform focuses MRI-guided sound waves to provide tremor treatment to patients with medication-refractory essential tremor and Parkinson’s disease.
Focused ultrasound has FDA approval to treat both sides of the body. Last fall, the company received positive coverage for its essential tremor therapy. In June, Insightec raised $150 million to support its incisionless neurosurgery technology.
Joining Insightec is an opportunity to be part of a team that is transforming patient care through groundbreaking technology,” Ghannam added. “I’m eager to contribute to this mission and help drive forward the innovative work that’s reshaping the future of medicine. To my new colleagues at Insightec, I’m excited to embark on this journey with you while pushing the boundaries of what’s possible in healthcare.
